Company profile
Creative Medical Technology Holdings, Inc.
NASDAQ: CELZ · Healthcare · Biotechnology
#1140 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
46DFH 31DQ 80GM 30SS 34
v0.1 · 65/100 weight · provisional
↑ balance-sheet leverage, disclosure history · ↓ Piotroski F, operating margin
Methodology →Revenue TTM
$3.0k
Rev growth YoY (TTM)
-50.0%
Net income (FY)
-$6.0M
Employees
4
as of 2026-08-24
Market cap
$3.4M
as of 2026-08-24
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$6.0k$6.0k2025
Net income-$6.0M-$6.0M2025
Operating income-$6.1M-$6.1M2025
Total assets$7.8M$7.8M2025
Liabilities$284.9k$284.9k2025
Equity$7.5M$7.5M2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Creative Medical Technology Holdings, Inc.’s revenue?
Creative Medical Technology Holdings, Inc. booked $6.0k in FY2025 revenue, contracting 45% year over year — slower than 80% of Healthcare companies we track, at a -99916.8% net margin.
Peers · Healthcare
Better Therapeutics, Inc.——Kaya Holdings, Inc.——Aspire Biopharma Holdings, Inc.17DAlaunos Therapeutics, Inc.33DOne World Products, Inc.——Pharmagen, Inc.——Neighbors
Maricopa →Key facts
CEOTimothy Warbington
SectorHealthcare
IndustryBiotechnology
HeadquartersPhoenix, AZ
ExchangeNASDAQ: CELZ
Employees4
IPO date2015-11-06
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.